Factors associated with non-adherence to three hypertension self-management behaviors: Preliminary data for a new instrument

Journal of General Internal Medicine

Volumn 28, Issue 1, 2013, Pages 99-106

  Crowley, Matthew J ^a,b   Grubber, Janet M ^a   Olsen, Maren K ^a,b   Bosworth, Hayden B ^a,b  

^a DURHAM VA MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

diet; exercise; hypertension; medication adherence; self management

Indexed keywords

ADULT; ARTICLE; CLINICAL ASSESSMENT; DEMOGRAPHY; DIASTOLIC BLOOD PRESSURE; DIET; EXERCISE; FEMALE; HEALTH BEHAVIOR; HEALTH BELIEF; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIMARY MEDICAL CARE; RISK FACTOR; SELF CARE; SELF REPORT; SOCIAL PSYCHOLOGY; SOCIOECONOMICS; SYSTOLIC BLOOD PRESSURE; TREATMENT REFUSAL;

AGED; ANTIHYPERTENSIVE AGENTS; ATTITUDE TO HEALTH; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; COMBINED MODALITY THERAPY; CROSS-SECTIONAL STUDIES; DIET; EXERCISE; FEMALE; HEALTH BEHAVIOR; HUMANS; HYPERTENSION; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NORTH CAROLINA; PATIENT COMPLIANCE; PRIMARY HEALTH CARE; PSYCHOMETRICS; RISK FACTORS; SELF CARE; SOCIOECONOMIC FACTORS;

EID: 84872490963     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-012-2195-1     Document Type: Article

References (47)

1. World Health Organization. Adherence to long-term therapies: evidence for action. Noncommunicable Diseases and Mental Health Adherence to long-term therapies project. 2003. http://www.who.int/chp/knowledge/publications/ adherence-Introduction.pdf. Accessed July 31, 2012.
2. Peterson AM, Takiya L, Finley R. Meta-analysis of trials of interventions to improve medication adherence. Am J Health Syst Pharm. 2003;60:657-65.
3. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010;303:2043-50.
4. Borzecki AM, Oliveria SA, Berlowitz DR. Barriers to hypertension control. Am Heart J. 2005;149:785-94.
5. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487-97.
6. Siegel D, Lopez J, Meier J. Antihypertensive medication adherence in the Department of Veterans Affairs. Am J Med. 2007;120:26-32.
7. Ren XS, Kazis LE, Lee A, Zhang H, Miller DR. Identifying patient and physician characteristics that affect compliance with antihypertensive medications. J Clin Pharm Ther. 2002;27:47-56.
8. Shea S, Misra D, Ehrlich MH, Field L, Francis CK. Predisposing factors for severe, uncontrolled hypertension in an inner-city minority population. N Engl J Med. 1992;327:776-81.
9. Francis CK. Hypertension, cardiac disease, and compliance in minority patients. Am J Med. 1991;91:29S-36.
10. Nabi H, Vahtera J, Singh-Manoux A, Pentti J, Oksanen T, Gimeno D, Elovainio M, Virtanen M, Klaukka T, Kivimaki M. Do psychological attributes matter for adherence to antihypertensive medication? The Finnish Public Sector Cohort Study. J Hypertens. 2008;26:2236-43.
11. Hassan NB, Hasanah CI, Foong K, Naing L, Awang R, Ismail SB, Ishak A, Yaacob LH, Harmy MY, Daud AH, Shaharom MH, Conroy R, Rahman AR. Identification of psychosocial factors of noncompliance in hypertensive patients. J Hum Hypertens. 2006;20:23-9.
12. Wang PS, Bohn RL, Knight E, Glynn RJ, Mogun H, Avorn J. Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors. J Gen Intern Med. 2002;17:504-11.
13. Patel RP, Taylor SD. Factors affecting medication adherence in hypertensive patients. Ann Pharmacother. 2002;36:40-5.
14. Gerber BS, Cho YI, Arozullah AM, Lee SY. Racial differences in medication adherence: A cross-sectional study of Medicare enrollees. Am J Geriatr Pharmacother. 2010;8:136-45.
15. Bosworth HB, Powers B, Grubber JM, Thorpe CT, Olsen MK, Orr M, Oddone EZ. Racial differences in blood pressure control: potential explanatory factors. J Gen Intern Med. 2008;23:692-8.
16. Morris AB, Li J, Kroenke K, Bruner-England TE, Young JM, Murray MD. Factors associated with drug adherence and blood pressure control in patients with hypertension. Pharmacotherapy. 2006;26:483-92.
17. Hill MN, Bone LR, Kim MT, Miller DJ, Dennison CR, Levine DM. Barriers to hypertension care and control in young urban black men. Am J Hypertens. 1999;12:951-8.
18. Kaplan S, Greenfield S, Ware JE. Assessing the effects of physician-patient interactions on the outcomes of chronic disease. Med Care. 1989;27:S110-27.
19. Krousel-Wood M, Islam T, Muntner P, Holt E, Joyce C, Morisky DE, Webber LS, Frohlich ED. Association of depression with antihypertensive medication adherence in older adults: cross-sectional and longitudinal findings from CoSMO. Ann Behav Med. 2010;40:248-57.
20. Aggarwal B, Mosca L. Lifestyle and psychosocial risk factors predict non-adherence to medication. Ann Behav Med. 2010;40:228-33.
21. Krousel-Wood MA, Frohlich ED. Hypertension and depression: coexisting barriers to medication adherence. J Clin Hypertens (Greenwich). 2010;12:481-6.
22. Eze-Nliam CM, Thombs BD, Lima BB, Smith CG, Ziegelstein RC. The association of depression with adherence to antihypertensive medications: a systematic review. J Hypertens. 2010;28:1785-95.
23. Bosworth H, Oddone E. A model of psychosocial and cultural antecedents of blood pressure control. J Natl Med Assoc. 2002;94:236-48.
24. Kressin NR, Orner MB, Manze M, Glickman ME, Berlowitz D. Understanding contributors to racial disparities in blood pressure control. Circ Cardiovasc Qual Outcomes. 2010;3:173-80.
25. Zeller A, Taegtmeyer A, Martina B, Battegay E, Tschudi P. Physicians' ability to predict patients' adherence to antihypertensive medication in primary care. Hypertens Res. 2008;31:1765-71.
26. McHorney CA. The Adherence Estimator: A brief, proximal screener for patient propensity to adhere to prescription medications for chronic disease. Curr Med Res Opin. 2009;25:215-38.
27. Zeller A, Schroeder K, Peters TJ. An adherence self-report questionnaire facilitated the differentiation between non-adherence and nonresponse to antihypertensive treatment. J Clin Epidemiol. 2008;61:282-8.
28. Schoberberger R, Janda M, Pescosta W, Sonneck G. The COMpliance Praxis Survey (COMPASS): A multidimensional instrument to monitor compliance for patients on antihypertensive medication. J Hum Hypertens. 2002;16:779-87.
29. Girerd X, Hanon O, Anagnostopoulos K, Ciupek C, Mourad JJ, Consoli S. Assessment of antihypertensive compliance using a self-administered questionnaire: Development and use in a hypertension clinic [in French]. Presse Med. 2001;30:1044-8.
30. Kim MT, Hill MN, Bone LR, Levine DM. Development and testing of the Hill-Bone Compliance to High Blood Pressure Therapy Scale. Prog Cardiovasc Nurs. 2000;15:90-6.
31. Bosworth HB, Olsen MK, Grubber JM, Neary AM, Orr MM, Powers BJ, Adams MB, Svetkey LP, Reed SD, Li Y, Dolor RJ, Oddone EZ. Two Self-management Interventions to Improve Hypertension Control: A Randomized Trial. Ann Intern Med. 2009;151:687-95.
32. Williams RB, Barefoot JC, Califf RM, Haney TL, Saunders WB, Pryor DB, Hlatky MA, Siegler IC, Mark DB. Prognostic importance of social and economic resources among medically treated patients with angiographically documented coronary artery disease. JAMA. 1992;267:520-4.
33. Parker RM, Baker DW, Williams MV, Nurss JR. The test of functional health literacy in adults: A new instrument for measuring patients' literacy skills. J Gen Intern Med. 1995;10:537-41.
34. Jette AM, Cummings KM, Brock BM, Phelps MC, Naessens J. The structure and reliability of health belief indices. Health Serv Res. 1981;16:81-98.
35. Bosworth HB, Olsen MK, Neary A, Orr M, Grubber J, Svetkey L, Adams M, Oddone EZ. Take Control of Your Blood pressure (TCYB) study: A multifactorial tailored behavioral and educational intervention for achieving blood pressure control. Patient Educ Couns. 2008;70:338-47.
36. Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE, Bullinger M, Kaasa S, Leplege A, Prieto L, Sullivan M. Cross-validation of item selection and scoring for the SF-12 health survey in nine countries: Results from the IQOLA project. J Clin Epidemiol. 1998;51:1171-8.
37. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67-74.
38. Lowry KP, Dudley TK, Oddone EZ, Bosworth HB. Intentional and unintentional non-adherence to antihypertensive medication. Ann Pharmacother. 2005;39:1198-203.
39. Allison PD. Logistic Regression Using the SAS System: Theory and Application. Cary, NC: SAS Institute Inc; 1999:49-50.
40. Svarstad BL, Chewning BA, Sleath BL, Claesson C. The Brief Medication Questionnaire: A tool for screening patient adherence and barriers to adherence. Patient Educ Couns. 1999;37:113-24.
41. Copher R, Buzinec P, Zarotsky V, Kazis L, Iqbal SU, Macarios D. Physician perception of patient adherence compared to patient adherence of osteoporosis medications from pharmacy claims. Curr Med Res Opin. 2010;26:777-85.
42. Voils CI, Hoyle RH, Thorpe CT, Maciejewski ML, Yancy WS Jr. Improving the measurement of self-reported medication non-adherence. J Clin Epidemiol. 2011;64:250-4.
43. Wang PS, Benner JS, Glynn RJ, Winkelmayer WC, Mogun H, Avorn J. How well do patients report noncompliance with antihypertensive medications?: a comparison of self-report versus filled prescriptions. Pharmacoepidemiol Drug Saf. 2004;13:11-9.
44. Feinstein A. Compliance bias and the interpretation of therapeutic trials. In: Haynes RB, Taylor DW, Sackeets DL, eds. Compliance in health care. Baltimore, M.D: The Johns Hopkins University Press; 1979:309-22.
45. Schroeder K, Fahey T, Hay AD, Montgomery A, Peters TJ. Adherence to antihypertensive medication assessed by self-report was associated with electronic monitoring compliance. J Clin Epidemiol. 2006;59:650-1.
46. Morisky DE, DiMatteo MR. Improving the measurement of self-reported medication non-adherence: response to authors. J Clin Epidemiol. 2011;64:255-7.
47. Cramer JA. Microelectronic systems for monitoring and enhancing patient compliance with medication regimens. Drugs. 1995;49:321-7.